What Happens When You Go on Ozempic But You’re Already Thin?

Key Points:

• GLP-1 agonist drugs like Ozempic and Mounjaro, originally intended for overweight or obese patients with related health conditions, are increasingly being used by individuals who are already thin, often for cosmetic weight loss purposes.
• Using these medications without medical supervision can lead to serious health risks including further weight loss, nutritional deficiencies, hormonal disruptions, decreased bone density, and loss of muscle mass.
• Mental health experts warn that GLP-1 use in underweight individuals can exacerbate body image issues, social withdrawal, and eating disorders, emphasizing the importance of professional support for those struggling with body image or disordered eating.
• The trend among celebrities to adopt extremely thin body types, possibly influenced by GLP-1 use, may be contributing to a resurgence of the "heroin chic" ideal and impacting public perceptions of beauty and health.
• Medical professionals caution against self-prescribing or "microdosing" these drugs without proper evaluation and monitoring, stressing that GLP-1s are powerful metabolic medications, not cosmetic supplements.